Cannabinoid CB2Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB1Mechanism that is Independent of CB2Receptors in Mice

MLA

Ken Mackie, et al. “Cannabinoid CB2Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB1Mechanism That Is Independent of CB2Receptors in Mice.” Journal of Pharmacology and Experimental Therapeutics, vol. 362, June 2017, pp. 296–305. EBSCOhost, https://doi.org/10.1124/jpet.117.241901.

APA

Ken Mackie, Andrea G. Hohmann, Lawrence M. Carey, & Ai-Ling Li. (2017). Cannabinoid CB2Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB1Mechanism that is Independent of CB2Receptors in Mice. Journal of Pharmacology and Experimental Therapeutics, 362, 296–305. https://doi.org/10.1124/jpet.117.241901

Chicago

Ken Mackie, Andrea G. Hohmann, Lawrence M. Carey, and Ai-Ling Li. 2017. “Cannabinoid CB2Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB1Mechanism That Is Independent of CB2Receptors in Mice.” Journal of Pharmacology and Experimental Therapeutics 362 (June): 296–305. doi:10.1124/jpet.117.241901.